Investing.com - Ocugen (NASDAQ: OCGN) reported third quarter EPS of $-0.060, $0.01 better than the analyst estimate of $-0.070. Revenue for the quarter came in at $0.00 versus the consensus...
In the third quarter of 2023, biopharmaceutical company Ocugen (NASDAQ:OCGN) made significant strides in the development of its pipeline assets, particularly in ophthalmic gene therapy...
Ocugen, Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today...
Ocugen, Inc. (OCGN) today announced that Connie Collingsworth, former Chief Operating Officer of the Bill and Melinda Gates Foundation, will join the Company’s Business Advisory Board (BAB)....
Ocugen, Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today...
Investing.com - Ocugen (NASDAQ: OCGN) reported second quarter EPS of $-0.100, $0.03 worse than the analyst estimate of $-0.070. Revenue for the quarter came in at $0.00 versus the consensus...
Effective August 14, 2023, Quan Vu is no longer serving as the Chief Financial Officer/Chief Business Officer, and as principal financial officer and principal accounting officer, of Ocugen...
Ocugen, Inc. (Nasdaq: NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced...
Ocugen, Inc. (Nasdaq: NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced...
Investing.com - Ocugen (NASDAQ: OCGN) reported first quarter EPS of $-0.070, $0.04 better than the analyst estimate of $-0.110. Revenue for the quarter came in at $0.00 versus the consensus...
Ocugen, Inc. (NASDAQ:OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the...
Ocugen (NASDAQ:OCGN), Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and...
Ocugen (NASDAQ:OCGN), Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and...
Ocugen (NASDAQ:OCGN), Inc. (Ocugen or the Company) (OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and...
Investing.com - Ocugen (NASDAQ: OCGN) reported fourth quarter EPS of $-0.100, in line with the analyst estimate of $-0.100. Revenue for the quarter came in at $0.00 versus the consensus...
Ocugen (NASDAQ:OCGN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
Ocugen, Inc. (NASDAQ:OCGN) today announced that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) to initiate a Phase 1 clinical...
Investing.com - Ocugen reported on Tuesday third quarter {{erl-942665||earnings that missed analysts' forecasts and revenue that was inline with expectations. Ocugen announced earnings per...
Ocugen (NASDAQ:OCGN) reported Q2 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
Pre-Open Stock Movers:VMware (NYSE:VMW) 20% HIGHER; Broadcom (NASDAQ:AVGO) is in advanced talks to acquire VMware (VMW), according to various media sources.SIGA Technologies, Inc. (SIGA) 17%...
Pre-Open Stock MoversRed Cat Holdings, Inc. (Nasdaq: RCAT) 21% HIGHER; a NATO country has secured an order of 15 Golden Eagle drone units for deployment in Ukraine.Twitter (NYSE:TWTR) 20%...
By Sam Boughedda Investing.com -- Ocugen, Inc. (NASDAQ:OCGN) dropped Friday after it announced the FDA declined to issue Emergency Use Authorization (EUA) approval for Covaxin, Covid-19...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, January 12th. Please refresh for updates. Biogen (NASDAQ:BIIB) stock slumped 8.5% after the U.S....
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, December 15th. Please refresh for updates. Eli Lilly (NYSE:LLY) stock rose 5.5% after the drug company...
By Dhirendra Tripathi Investing.com – Ocugen stock (NASDAQ:OCGN) climbed 7% in Wednesday’s premarket trading after the company said it has data suggesting its Covid-19 vaccine could provide...
By Sam Boughedda Investing.com — Ocugen, Inc (NASDAQ:OCGN) told investors Monday that it has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Healthcare, Technology and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Basic Materials and Healthcare sectors propelled shares higher while losses in the Technology,...
By Christiana Sciaudone Investing.com -- Meme stock Ocugen (NASDAQ:OCGN) soared 20% as it may have discovered a vaccine against the Brazil Covid-19 variant. Scientists at Indian Council of...
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Basic Materials, Oil & Gas and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
(Adds details on U.S. vaccine orders, trials in children, no comments from FDA, HHS)By Krishna N. DasNEW DELHI, March 15 (Reuters) - Ocugen Inc OCGN.O seeks to sell 100 million doses of...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Technology, Consumer Services and Industrials sectors propelled shares higher while losses in the Oil & Gas,...
By Anuron Kumar MitraBENGALURU, Feb 18 (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vaccine, COVAXIN, in more than 40...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Oil & Gas, Industrials and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Basic Materials, Consumer Goods and Oil & Gas sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Industrials, Financials and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
